Literature DB >> 28352057

Paroxysmal Kinesigenic Dyskinesia as the Presenting and Only Manifestation of Multiple Sclerosis after Eighteen Months of Follow-Up.

Marius Baguma1,2, Michel Ossemann1,3.   

Abstract

Other than tremor, movement disorders are uncommon in multiple sclerosis. Among these uncommon clinical manifestations, paroxysmal kinesigenic dyskinesia is the most frequently reported. It is characterized by episodic attacks of involuntary movements that are induced by repetitive or sudden movements, startling noise or hyperventilation. The diagnosis is essentially clinical and based on a good observation of the attacks. It is very easy to misdiagnose it. We describe the case of a young female patient who presented paroxysmal kinesigenic dyskinesia as the first and only clinical manifestation of multiple sclerosis, with no recurrence of attacks nor any other neurologic symptom after eighteen months of follow-up.

Entities:  

Keywords:  MRI lesions; Movement disorders; multiple sclerosis; paroxysmal kinesigenic dyskinesia

Year:  2017        PMID: 28352057      PMCID: PMC5435831          DOI: 10.14802/jmd.16055

Source DB:  PubMed          Journal:  J Mov Disord        ISSN: 2005-940X


  10 in total

1.  Diagnosis and treatment of paroxysmal dyskinesias revisited.

Authors:  Iris Unterberger; Eugen Trinka
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

2.  Paroxysmal dystonia as a rare initial manifestation of multiple sclerosis.

Authors:  Sanem Yilmaz; Gul Serdaroglu; Sarenur Gokben; Hasan Tekgul
Journal:  J Child Neurol       Date:  2011-06-14       Impact factor: 1.987

3.  Paroxysmal kinesigenic dyskinesia.

Authors:  A T Alibhoy; Subhashie Wijemanne; Ranjanie Gamage
Journal:  Ceylon Med J       Date:  2006-03

Review 4.  Paroxysmal dyskinesias.

Authors:  Kailash P Bhatia
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 5.  Movement disorders in multiple sclerosis and other demyelinating diseases.

Authors:  Raja Mehanna; Joseph Jankovic
Journal:  J Neurol Sci       Date:  2013-03-19       Impact factor: 3.181

6.  Paroxysmal dyskinesias: clinical features and classification.

Authors:  M Demirkiran; J Jankovic
Journal:  Ann Neurol       Date:  1995-10       Impact factor: 10.422

7.  Secondary paroxysmal dyskinesias.

Authors:  Jaishri Blakeley; Joseph Jankovic
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

8.  Kinesigenic paroxysmal hemidyskinesia as the initial presentation of multiple sclerosis.

Authors:  Yara Dadalti Fragoso; Mauro Gomes Araujo; Nilton Luiz Branco
Journal:  MedGenMed       Date:  2006-10-04

Review 9.  Movement disorders in multiple sclerosis.

Authors:  C Tranchant; K P Bhatia; C D Marsden
Journal:  Mov Disord       Date:  1995-07       Impact factor: 10.338

10.  Analyzing clinical and electrophysiological characteristics of Paroxysmal Dyskinesia.

Authors:  Jue-Qian Zhou; Lie-Min Zhou; Zi-Yan Fang; Qian Wang; Zi-Yi Chen; Li-Bai Yang; Su-da Chen; Xiao-Dong Cai
Journal:  J Res Med Sci       Date:  2011-01       Impact factor: 1.852

  10 in total
  2 in total

1.  Lesion correlates of secondary paroxysmal dyskinesia in multiple sclerosis.

Authors:  Kilian Fröhlich; Klemens Winder; Ralf A Linker; Konstantin Huhn; Tobias Engelhorn; Arnd Dörfler; De-Hyung Lee; Stefan Schwab; Frank Seifert
Journal:  J Neurol       Date:  2018-07-31       Impact factor: 4.849

Review 2.  Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in China.

Authors:  Li Cao; Xiaojun Huang; Ning Wang; Zhiying Wu; Cheng Zhang; Weihong Gu; Shuyan Cong; Jianhua Ma; Ling Wei; Yanchun Deng; Qi Fang; Qi Niu; Jin Wang; Zhaoxia Wang; You Yin; Jinyong Tian; Shufen Tian; Hongyan Bi; Hong Jiang; Xiaorong Liu; Yang Lü; Meizhen Sun; Jianjun Wu; Erhe Xu; Tao Chen; Tao Chen; Xu Chen; Wei Li; Shujian Li; Qinghua Li; Xiaonan Song; Ying Tang; Ping Yang; Yun Yang; Min Zhang; Xiong Zhang; Yuhu Zhang; Ruxu Zhang; Yi Ouyang; Jintai Yu; Quanzhong Hu; Qing Ke; Yuanrong Yao; Zhe Zhao; Xiuhe Zhao; Guohua Zhao; Furu Liang; Nan Cheng; Jianhong Han; Rong Peng; Shengdi Chen; Beisha Tang
Journal:  Transl Neurodegener       Date:  2021-02-16       Impact factor: 8.014

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.